Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.
Weiguang XueRinat RibalovZheng-Yi ZhouRajeev AyyagariSam LeoPublished in: Journal of medical economics (2021)
Keyphrases